CUV 1.49% $14.34 clinuvel pharmaceuticals limited

The AK / SCC 24 month phase II study was supposed to end in...

  1. 93 Posts.
    The AK / SCC 24 month phase II study was supposed to end in August 2012. Has I missed something or has Clinuvel just "forgotten" to release the results? Or can we expect the data to be released in early 2013? I really don't hope they threw this one away. AK / SCC would be a huge leap towards general cancer protection. Comments? Happy New Year
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.34
Change
0.210(1.49%)
Mkt cap ! $712.3M
Open High Low Value Volume
$14.14 $14.39 $14.14 $623.1K 43.69K

Buyers (Bids)

No. Vol. Price($)
18 333 $14.34
 

Sellers (Offers)

Price($) Vol. No.
$14.37 1212 12
View Market Depth
Last trade - 15.24pm 15/10/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.